EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor and Nodal Disease Growth Rates in Patients with Oropharyngeal Squamous Cell Carcinoma

Nicole I Farber iD, Yimin Li, Roberto N Solis, Joy Chen, Zahrah Masheeb, Machelle Wilson iD, Arnaud F Bewley, Marianne Abouyared, Shyam Rao, Yi Rong, Andrew C Birkeland

Cancers · 29.07.2023 · 15 (15) · 3865

DOI: 10.3390/cancers15153865 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 29.07.2023. Verfasst von Nicole I Farber und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of California Davis, Sacramento, CA 95817, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS, the Key Medical and Health Projects in Xiamen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Though specific growth rate (SGR) has potential prognostic value for oropharyngeal squamous cell carcinoma (OPSCC), there is sparse literature defining these rates. Our aims were to establish the SGRs of primary tumors (PTs) and lymph nodes (LNs) in OPSCC and to correlate SGR with oncologic outcome. A pilot study was designed with a retrospective analysis examining 54 patients from the University of California, Davis with OPSCC (diagnosed 2012–2019). Radiation oncology software and pretreatment serial CT scans were used to measure PT and LN volumes to calculate SGR and doubling time (DT). The mean PT-SGR was 1.2 ± 2.2%/day and the mean LN-SGR was 1.6 ± 1.9%/day. There was no statistically significant difference between slow-growing and fast-growing cohorts in terms of age, gender, smoking status, tumor subsite, HPV status (as determined with p16 staining), initial volume, or overall stage. SGR had no impact on 2-year overall survival, disease-free survival, or disease-specific survival. We found the average daily growth rates for OPSCC to be 1.2%/day and 1.6%/day. Our findings suggest PT- and LN-SGR are independent factors, not heavily influenced by known biomarkers and patient characteristics, without a statistical impact on prognosis. This information has value in patient counseling regarding tumor growth and in providing patients worried about fast-growing tumors the appropriate reassurance.

Schlagwörter

Stichwörter der Autor:innen

oropharyngealsquamous cell carcinomatumor growth

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, University of California Davis, Sacramento, CA 95817, USA.
  • Department of Radiation Oncology, University of California Davis, Sacramento, CA 94720, USA.
  • Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361005, China.
  • Davis-School of Medicine, University of California, Sacramento, CA 94720, USA.
  • Department of Radiation Oncology, Mayo Clinic, Pheonix, AZ 85054, USA.

ORCID-Profile: Nicole I Farber, Machelle Wilson

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS
  • the Key Medical and Health Projects in Xiamen
  • National Center for Advancing Translational Sciences, National Institutes of Health

Zitieren

APA

Farber, N. I., Li, Y., Solis, R. N., Chen, J., Masheeb, Z., Wilson, M., Bewley, A. F., Abouyared, M., Rao, S., Rong, Y., & Birkeland, A. C. (2023). Tumor and Nodal Disease Growth Rates in Patients with Oropharyngeal Squamous Cell Carcinoma. Cancers, 15(15), 3865. https://doi.org/10.3390/cancers15153865

Vancouver

Farber NI, Li Y, Solis RN, Chen J, Masheeb Z, Wilson M, et al. Tumor and Nodal Disease Growth Rates in Patients with Oropharyngeal Squamous Cell Carcinoma. Cancers. 2023;15(15):3865. doi:10.3390/cancers15153865

BibTeX
@article{Farber2023,
  author = {Farber, Nicole I and Li, Yimin and Solis, Roberto N and Chen, Joy and Masheeb, Zahrah and Wilson, Machelle and Bewley, Arnaud F and Abouyared, Marianne and Rao, Shyam and Rong, Yi and Birkeland, Andrew C},
  title = {Tumor and Nodal Disease Growth Rates in Patients with Oropharyngeal Squamous Cell Carcinoma},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {15},
  pages = {3865},
  doi = {10.3390/cancers15153865}
}
Kostenlos starten →